Rubraca-Approved for Indications in the U.S.
- DOWNLOAD FULL U.S. PRESCRIBING INFORMATION
- DOWNLOAD DEAR HEALTHCARE PROFESSIONAL LETTER JUNE 2022
- REQUEST U.S. MEDICAL INFORMATION
Rubraca Authorized for Indication in Europe
If a healthcare provider in Europe, for more information see news release.
Medical Information - Adverse Events or Product Quality Complaints
In the U.S., to report an adverse event related to use of a Clovis product, or if you have a product quality complaint, please contact the Medical Information department at 1-415-409-7220 (US toll), 1-844-CLVS ONC (1-844-258-7662; US toll-free), by email at firstname.lastname@example.org.
In Europe, to report an adverse event related to use of a Clovis product, or if you have a product quality complaint, please click here for our country specific contact details